金河生物(002688) - 2015年11月19日投资者关系活动记录表

Group 1: Company Overview - The company, Jinhe Biological Technology Co., Ltd., has over 20 years of development and primarily engages in the production and sales of feed additives, with a focus on feed-grade chlortetracycline [2][3] - Jinhe is the largest global producer of feed-grade chlortetracycline [3] Group 2: Product Functions - Feed-grade chlortetracycline is used to promote animal growth, improve feed conversion rates, and prevent animal diseases. It can reduce mortality rates and increase weight gain and feed conversion rates when fed at low doses [3] Group 3: Fundraising and Financials - The total amount raised from the non-public offering of shares is 47.34 million yuan, with the net proceeds intended to supplement the company's working capital after deducting issuance costs. Approval from the China Securities Regulatory Commission is still pending [3][4] Group 4: Raw Material Impact - The cost of corn, which constitutes approximately 30% to 50% of the company's main business costs, is influenced by various factors including climate, national corn reserve policies, and supply-demand relationships [4]